SCHEMBL19743718

SCHEMBL19743718

COC(=O)c1cc(=O)c2cc(Cl)cc(OC)c2o1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 7/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.47
CSNK2A2 P19784 3/20 0.45
CSNK2B P67870 3/20 0.45
CSNK2A1 P68400 3/20 0.45
MAOB P27338 1/20 0.43
CYP1A1 P04798 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP1B1 Q16678 2/20 0.41
MAPT P10636 2/20 0.41
DUSP3 P51452 1/20 0.40
KMT2A Q03164 1/20 0.40
PTPN11 Q06124 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19743758 0.87 GPR35 (0.59) GPR35KDM4ETP53CSNK2A2CSNK2B
SCHEMBL19744065 0.84 GPR35 (0.47) GPR35KDM4ELMNATP53CSNK2A2
SCHEMBL19744145 0.83 GPR35 (0.50) GPR35KDM4ELMNATP53CYP1A1
SCHEMBL8115765 0.79 ALDH1A1 (0.57) GPR35KDM4ELMNAMAPTKMT2A
SCHEMBL31634948 0.74 MAOB (0.73) KDM4ECSNK2A2CSNK2BCSNK2A1MAOB
SCHEMBL31619651 0.74 MAOB (0.73) KDM4ECSNK2A2CSNK2BCSNK2A1MAOB
SCHEMBL21858342 0.74 TP53 (0.62) GPR35KDM4ETP53CSNK2A2CSNK2B
SCHEMBL18384641 0.74 TSHR (0.45) KDM4ELMNAMAPT
SCHEMBL14459505 0.74 KDM4E (0.65) KDM4ELMNAMAOBMAPTKMT2A
SCHEMBL29394302 0.73 LMNA (0.62) GPR35KDM4ELMNATP53CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641864-B Anti-infective agents 邓迪大学 2023-04-04 CN disclosed
US-11485720-B2 Anti-infective agents UNIVERSITY OF DUNDEE (GB) 2022-11-01 US disclosed
EP-3472141-B1 ANTI-INFECTIVE AGENTS UNIV DUNDEE (GB) 2022-10-05 EP disclosed
US-20210101877-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2021-04-08 US disclosed
US-20210101877-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2021-04-08 US disclosed
US-20190225592-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2019-07-25 US disclosed
US-20190225592-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2019-07-25 US disclosed
EP-3472141-A1 ANTI-INFECTIVE AGENTS University Of Dundee (GB) 2019-04-24 EP disclosed
WO-2017221002-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11485720-B2 Anti-infective agents C1R, RRS1, ARG1 GPR35 3114/4885KDM4E 2159/4885LMNA 2536/4885
US-20210101877-A1 ANTI-INFECTIVE AGENTS C1R, RRS1, ARG1 GPR35 3114/4885KDM4E 2159/4885LMNA 2536/4885
US-20190225592-A1 ANTI-INFECTIVE AGENTS C1R, ARG1, MSR1 GPR35 3007/4885KDM4E 2344/4885LMNA 2610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.